Real-world First-line Sugemalimab-Chemotherapy in Advanced NSCLC
Clinical trial NCT07247227 · RECRUITING
Trial details
- NCT number
- NCT07247227
- Sponsor
- Peking Union Medical College
- Status
- RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2023-10-10
- Primary completion
- 2027-05-01
- Enrollment
- 150
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.